T1	Participants 327 383	completed RT in patients with head and neck cancer (HNC)
T2	Participants 435 495	Sixty-six consecutive patients from two RT clinics in Sweden
T3	Participants 1552 1602	CONCLUSIONS Patients with HNC undergoing high dose
